Ajax Engineering IPO share allotment likely today: Check status, listing date and other details

Ajax Engineering IPO share allotment likely today: Check status, listing date and other details

Ajax Engineering received decent response from investors for its IPO as the issue was subscribed just over 6.4 times. The company will finalise the share allotment process later today. Investors can check Ajax Engineering IPO allotment status through BSE and also via the registrar’s website.

Firstly, here’s how you check Dr Agarwal’s Healthcare IPO allotment on BSE

Step 1: Visit the BSE Website (https://www.bseindia.com/investors/appli_check.aspx)

Step 2: Please select the issue name, that is the company’s name in the drop down.

Step 3: Enter the application number or PAN number to check the allotment status.

Check Ajax Engineering IPO allotment through Link Intime India

Step 1: Visit the Link Intime India website (https://linkintime.co.in/initial_offer/public-issues.html)

Step 2: Select Ajax Engineering IPO

Step 3: Enter the PAN details and click search to know the status

What is the latest Ajax Engineering GMP

In line with the subdued response for the IPO, Dr Agarwal’s Healthcare GMP on allotment day is marginal at Rs 13, reflecting a premium of 2% over the issue price. The listing is scheduled on February 17.

Ajax Engineering IPO details

The company will not receive any proceeds of the offer. Each of the selling shareholders will be entitled to the respective proportion of proceeds of the OFS after deducting its portion of the offer related expenses.

Ajax is a leading concreting equipment player renowned for both its engineering expertise as well as product after-sales support network. The company was established in the year 1992 for manufacturing self-loading concrete mixers and today is the global leader in this product.

Over the years, the company has evolved by adapting to the needs of its customers with a clear and consistent goal towards becoming the most customer-centric organization.

For the last three fiscal years, the company has posted an average EPS of Rs 8.83 (basic) and an average RoNW of 15.77%. The issue is priced at a P/BV of 7.23 based on its NAV of Rs 87.04 as of September 2024, as well as on post-IPO basis.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)

via



Call Us Now
WhatsApp